• Home
  • Search Results

Search Results

Young Adult (18-34)
2348 studies match your search

Study of Camizestrant in Patients with ER+/HER2- Early Breast Cancer

This is a Phase III study to help us improve outcomes of patients with ER+/HER2- early breast cancer with intermediate or high risk for disease recurrence. This study is for patients who have completed definitive locoregional therapy and standard adjuvant endocrine therapy for at least 2 years and up to 5 years without disease recurrence. In this study, we want to learn if a new oral "SERD" therapy called Camizestrant is helpful in reducing chance of recurrence. Talk to your Medical Oncologist for more information about this trial.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Breast)
Visit Location

PRO-VISION: Patient Reported Outcomes-Based Monitoring of VEGF-Inhibitor Side Effects in Oncology

This is a research study to investigate how collecting information about treatment-related side effects directly from patients can help manage the side effects associated with certain oral chemotherapies in patients with metastatic renal cell carcinoma.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Kidney)
Visit Location

Myelofibrosis Treatment Study

The purpose of this study is to learn more about the safety and effectiveness of the study drug (INCB057643) as monotherapy for participants with relapsed or refractory myelofibrosis.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia)

Improve Adherence to Childhood Cancer Survivorship

The purpose of this study is to learn more about how to motivate survivors to get recommended health screening after their treatment is complete.

Age & Gender
  • 0 years ~ 21 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Pediatric Cancers)

Long-Term Follow-Up in Women with Early Breast Cancer

The purpose of this research study is to learn whether there are pre-treatment factors that impact quality of life and function 3 years or more after primary treatment of breast cancer. The factors we will look at in this study may include patient characteristics, specific breast cancer diagnosis, treatments, toxicities or adverse events during treatment.

Age & Gender
  • 21 years ~ 99 years
  • Female
Study Interest
  • Cancer (Breast)
Open

Understanding Outcome Differences in Adolescents and Young Adults with Acute Lymphoblastic Leukemia (ALL)

If you or your child has been diagnosed with acute lymphoblastic leukemia (ALL), you or they might be able to take part in a research study. This study aims to understand why there are differences in outcomes in adolescents and young adults treated for ALL.

Age & Gender
  • 15 years ~ 39 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Pediatric Cancers, Leukemia)
  • Child and Teen Health
Not currently enrolling

Biomarkers of COVID-19-related social stress in healthcare workers

In this study, we want to learn more about how stress related to COVID-19 can affect behaviors and the way that genes work (epigenetics) in healthcare workers. This study focuses on healthcare workers because they are in the frontline of the pandemic.

Age & Gender
  • 25 years ~ 50 years
  • Male, Female, Gender Inclusive
Study Interest
  • Mental and Emotional Health
  • UNC or UNC Health employees
  • COVID-19
Not currently enrolling

MiSLE Stem Cell Study for Lupus

The purpose of this study is to see whether an infusion of stem cells improves lupus disease activity when compared with a placebo infusion. Other studies have shown that stem cells help reduce inflammation and are thought to be safe. This study will help confirm whether this is an effective and safe treatment for lupus.

Age & Gender
  • 18 years ~ 65 years
  • Male, Female, Gender Inclusive
Study Interest
  • Bones, Joints, Muscles
  • Chronic Conditions
Not currently enrolling

Russian Second Language Acquisition Study

In this study, we want to find out more about how adults learn a second language, specifically how native speakers of America English learn Russian.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Language and Speech
  • UNC Students (undergrad, grad, professional)
Visit Location
Not currently enrolling

North Carolina Victims of Crime Needs Assessment

In this study, we want to learn if existing services meet the needs of people who experience crime in North Carolina. Specifically, we will focus on whether these services meet the needs of crime victims from historically underserved populations. We also want to learn whether service accessibility is different across the state. Although the assessment is meant to cover all North Carolinians, the GCC and research team have identified specific priority populations, including: veterans, immigrants, refugees, people with disabilities, older adults, LGBTQ+ individuals, teens, people from religious minority groups, people who are unhoused/experiencing homelessness, co-victims of homicide, indigenous communities, people with limited English proficiency, and people of color.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Aging
  • Injury/Injury Prevention
  • Mental and Emotional Health
  • and 7 more
Visit Location
100% Remote (online, phone, text)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research